Rare mutations have been reported and more recently dominantnegative variants of the receptor were identified although the biologicalimpact remains to be established firmly [179].Similarly, altered isoforms may be overexpressed in cancer [180–183].Cytogenetic rearrangement has been identified in follicular thyroid cancerfusing the PAX-8 transcription factor to PPARγ. This evidence concerns the gene PPARG and cancer.